Health-related quality of life in chronic kidney disease patients

Primary Psychiatry

Volumn 15, Issue 1, 2008, Pages 46-51

  Mucsi, Istvan ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; CHRONIC KIDNEY DISEASE; HUMAN; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; REVIEW; SOCIAL ASPECT; VALIDITY;

EID: 38349101078     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney. 2002;39(2 suppl 1):1-266.
2. Mingardi G, Cornalba L, Cortinovis E, Ruggiata R, Mosconi P, Apolone G. Health-related quality of life in dialysis patients. A report from an Italian study using the SF-36 Health Survey. DIA-QOL Group. Nephrol Dial Transplant. 1999;14(6):1503-1510.
3. Cameron JI, Whiteside C, Katz J, Devins GM. Differences in quality of life across renal replacement therapies: a meta-analytic comparison. Am J Kidney Dis. 2000;35(4):629-637.
4. II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. Am J Kidney Dis 2006;47(5 suppl 3):16-85.
5. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334(13):835-840.
6. DeOreo PB. Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis. 1997;30(2):204-212.
7. Mapes DL, Lopes AA, Satayathum S, et al. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 2003;64(1):339-349.
8. Devins GM. Illness intrusiveness and the psychosocial impact of lifestyle disruptions in chronic life-threatening disease. Adv Ren Replace Ther. 1994;1(3):251-263.
9. Devins GM, Mann J, Mandin H, et al. Psychosocial predictors of survival in end-stage renal disease. J Nerv Ment Dis. 1990;178(2):127-133.
10. Devins GM, Beanlands H, Mandin H, Paul LC. Psychosocial impact of illness intrusiveness moderated by self-concept and age in end-stage renal disease. Health Psychol. 1997;16(6):529-538.
11. Testa MA. Interpretation of quality-of-life outcomes: issues that affect magnitude and meaning. Med Care. 2000;38(9 suppl):166-174.
12. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994;3(5):329-338.
13. Mapes DL, Bragg-Gresham JL, Bommer J, et al. Health-related quality of life in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44(5 suppl 2):54-60.
14. Unruh M, Benz R, Greene T, et al. Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study. Kidney Int. 2004;66(1):355-366.
15. Knight EL, Ofsthun N, Teng M, Lazarus JM, Curhan GC. The association between mental health, physical function, and hemodialysis mortality. Kidney Int. 2003;63(5):1843-1851.
16. Korevaar JC, Merkus MP, Jansen MA, Dekker FW, Boeschoten EW, Krediet RT. Validation of the KDQOL-SF: a dialysis-targeted health measure. Qual Life Res. 2002;11(5):437-447.
17. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB, Kamberg C. Kidney Disease Quality of Life Short Form (KDQOL-SF), Version 1.3: A Manual for Use and Scoring. Santa Monica, CA: RAND P-7994; 1997.
18. Khan IH, Garratt AM, Kumar A, et al. Patients' perception of health on renal replacement therapy: evaluation using a new instrument. Nephrol Dial Transplant. 1995;10(5):684-689.
19. Wight JP, Edwards L, Brazier J, Walters S, Payne JN, Brown CB. The SF36 as an outcome measure of services for end stage renal failure. Qual Health Care. 1998;7(4);209-221.
20. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol. 2001;12(12):2797-2806.
21. Barotfi S, Molnar MZ, Almasi C, et al. Validation of the Kidney Disease Quality of Life-Short Form questionnaire in kidney transplant patients. J Psychosom Res. 2006;60(5):495-504.
22. Bradley C. Importance of differentiating health status from quality of life. Lancet. 2001;357(9249):7-8.
23. Addington-Hall J, Kalra L. Who should measure quality of life? BMJ. 2001;322(7299):1417-1420.
24. Hickey AM, Bury G, O'Boyle CA, Bradley F, O'Kelly FD, Shannon W. A new short form individual quality of life measure (SEIQOL-DW): application in a cohort of individuals with HIV/AIDS. BMJ. 1996;313(7048):29-33.
25. Bradley C. Design of a renal-dependent individualized quality of life questionnaire. Adv Perit Dial. 1997;13:116-120.
26. Bradley C, Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab Res Rev. 2002;18(suppl 3):64-69.
27. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQOL. Qual Life Res. 1999;8(1-2):79-91.
28. Birmele B, Francois M, Pengloan J, et al. Death after withdrawal from dialysis: the most common cause of death in a French dialysis population. Nephrol Dial Transplant. 2004;19(3):686-691
29. Cohen LM, Germain MJ. The psychiatric landscape of withdrawal. Semin Dial. 2005;18(2):147-153
30. Leidy NK, Revicki DA, Geneste B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health. 1999;2(2):113-127.
31. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79.
32. Kind P. US FDA guidance: apropos of PROs. Pharmacoeconomics. 2006;24(9):833-836.
33. Kalantar-Zadeh K, Unruh M. Health related quality of life in patients with chronic kidney disease. Int Urol Nephrol. 2005;37(2):367-378.
34. Unruh ML, Weisbord SD, Kimmel PL. Health-related quality of life in nephrology research and clinical practice. Semin Dial. 2005;18(2):82-90.
35. Rocco MV, Gassman JJ, Wang SR, Kaplan RM. Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. Am J Kidney Dis. 1997;29(6):888-896.
36. Jofre R, Lopez-Gomez JM, Moreno F, Sanz-Guajardo D, Valderrabano F. Changes in quality of life after renal transplantation. Am J Kidney Dis. 1998;32(1):93-100.
37. Simmons RG, Abress L. Quality-of-life issues for end-stage renal disease patients. Am J Kidney Dis. 1990;15(3):201-208.
38. Kimmel PL, Peterson RA, Weihs KL, et al. Aspects of quality of life in hemodialysis patients. J Am Soc Nephrol. 1995;6(5):1418-1426.
39. Van Manen JG, Korevaar JC, Dekker FW, Boeschoten EW, Bossuyt PM, Krediet RT. Adjustment for comorbidity in studies on health status in ESRD patients: which comorbidity index to use? J Am Soc Nephrol. 2003;14(2):478-485.
40. Kizilisik AT, Feurer ID, VanBuren DH, et al. Effects of diabetes and cadaveric organs on functional performance and health-related quality of life after kidney transplantation. Am J Surg. 2003;186(5):535-539.
41. Martinez-Castelao A, Gorriz JL, Garcia-Lopez F, Lopez-Revuelta K, De Alvaro F, Cruzado JM. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study). J Nephrol. 2004;17(4):544-551.
42. Sorensen VR, Mathiesen ER, Watt T, Bjorner JB, Andersen MV, Feldt-Rasmussen B. Diabetic patients treated with dialysis: complications and quality of life. Diabetologia. 2007;50(11):2254-2262.
43. Silverberg DS, Wexler D, Blum M, et al. Effects of treatment with epoetin beta on outcomes in patients with anaemia and chronic heart failure. Kidney Blood Press Res. 2005;28(1):41-47.
44. Hosokawa S, Yoshida O. Effect of erythropoietin (rHuEPO) on trace elements and quality of life (QOL) in chronic hemodialysis patients. Int J Clin Pharmacol Ther. 1994;32(8):415-421.
45. Kimmel PL, Patel SS. Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis. Semin Nephrol. 2006;26(1):68-79.
46. Lefebvre P, Vekeman F, Sarokhan B, Enny C, Provenzano R, Cremieux PY. Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa. Curr Med Res Opin. 2006;22(10):1929-1937.
47. Kalantar-Zadeh K, Fouque D, Kopple JD. Outcome research, nutrition, and reverse epidemiology in maintenance dialysis patients. J Ren Nutr. 2004;14(2):64-71.
48. Kalender B, Ozdemir AC, Dervisoglu E, Ozdemir O. Quality of life in chronic kidney disease: effects of treatment modality, depression, malnutrition and inflammation. Int J Clin Pract. 2007;61(4):569-576.
49. Simmons RG, Anderson C, Kamstra L. Comparison of quality of life of patients on continuous ambulatory peritoneal dialysis, hemodialysis, and after transplantation. Am J Kidney Dis. 1984;4(3):253-255.
50. Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 1996;50(1):235-242.
51. Rebollo P, Ortega F, Baltar JM, et al. Health related quality of life (HRQOL) of kidney transplanted patients: variables that influence it. Clin Transplant. 2000;14(3):199-207.
52. Muehrer RJ, Becker BN. Life after transplantation: new transitions in quality of life and psychological distress. Semin Dial. 2005;18(2):124-131.
53. Buoncristiani U. Fifteen years of clinical experience with daily haemodialysis. Nephrol Dial Transplant. 1998;13(suppl 6):148-151.
54. Kooistra MP, Vos J, Koomans HA, Vos PF. Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant. 1998;13(11):2853-2860.
55. McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA. The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int. 2003;64(3):1004-1011.
56. Kutner NG. Quality of life and daily hemodialysis. Semin Dial. 2004;17(2):92-98.
57. Evans RW, Manninen DL, Garrison LP Jr, et al. The quality of life of patients with end-stage renal disease. N Engl J Med. 1985;312(9):553-559.
58. Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang H, Lazarus JM. Quality-of-life evaluation using Short Form 36: comparison in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 2000;35(2):293-300.
59. Novak M, Mendelssohn D, Shapiro CM, Mucsi I. Diagnosis and management of sleep apnea syndrome and restless legs syndrome in dialysis patients. Semin Dial. 2006;19(3):210-216.
60. Novak M, Shapiro CM, Mendelssohn D, Mucsi I. Diagnosis and management of insomnia in dialysis patients. Semin Dial. 2006;19(1):25-31.
61. Unruh M. Sleep disorders in chronic kidney disease. Primary Psychiatry. 2008;15(1):57-63.
62. Mucsi I, Molnar MZ, Ambrus C, et al. Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrol Dial Transplant. 2005;20(3):571-577.
63. Unruh ML, Levey AS, D'Ambrosio C, Fink NE, Powe NR, Meyer KB. Restless legs symptoms among incident dialysis patients: association with lower quality of life and shorter survival. Am J Kidney Dis. 2004;43(5):900-909.
64. Kimmel PL. Depression in patients with chronic renal disease: what we know and what we need to know. J Psychosom Res. 2002;53(4):951-956.
65. Kimmel PL. Psychosocial factors in chronic kidney disease patients. Semin Dial. 2005;18(2):71-72
66. Kimmel PL, Peterson RA, Weihs KL, et al. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int. 2000;57(5):2093-2098.
67. Zalai DM, Novak M. Depressive disorders in patients with chronic kidney disease. Primary Psychiatry. 2008;15(1):66-72.
68. Lopes AA, Bragg J, Young E, et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int. 2002;62(1):199-207.
69. Cukor D. Use of CBT to treat depression among patients on hemodialysis. Psychiatr Serv. 2007;58(5):711-712.
70. Cukor D, Coplan J, Brown C, et al. Depression and anxiety in urban hemodialysis patients. Clin J Am Soc Nephrol. 2007;2(3):484-490.
71. Cukor D, Peterson RA, Cohen SD, Kimmel PL. Depression in end-stage renal disease hemodialysis patients. Nat Clin Pract Nephrol. 2006;2(12):678-687.
72. Baines LS, Joseph JT, Jindal RM. Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants. Kidney Int. 2004;65(5):1937-1942.
73. Fukuhara S, Yamazaki S, Hayashino Y, Green J. Measuring health-related quality of life in patients with end-stage renal disease: why and how. Nat Clin Pract Nephrol. 2007;3(7):352-353.
74. Farmer ER, Gonin R, Hanna MP. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol. 1996;27(6):528-531.
75. Delco F, Sonnenberg A. Limitations of the faecal occult blood test in screening for colorectal cancer. Ital J Gastroenterol Hepatol. 1999;31(2):119-126.
76. Sonnenberg A. We only see what we already know - a modified Bayes' formula to explain inherent limitations of diagnostic tests. Med Hypotheses. 2004;63(4):759-763.
77. Revicki DA, Cella DF. Health status assessment for the twenty-first century: item response theory, item banking and computer adaptive testing. Qual Life Res. 1997;6(6):595-600.